Vaccines against Ovine Toxoplasmosis: History, Advances and Current status


  • Rawaz Mhamad Jaza Sulaiman MSc. Biomedical Sciences, Sulaimani Veterinary Directorate, Kurdistan Region, Iraq. Author



Toxoplasmosis, Immunity against T.gondi, Vaccines in sheep, DNA vaccines


Toxoplasmosis is a common and wide spread global disease, caused by a protozoan parasite, Toxoplasma gondii. The condition afflicts both animal and human, causing abortion and congenital defects. Hence, it is of a huge veterinary and medical concern. With on-going researches, the mechanism of the disease is better appreciated nowadays. Developing a vaccine for veterinary use, more precisely for sheep will not only gain economic advantages, but it will also bring insight into discovering one for human use as well. Until now, the only available commercial vaccine in sheep is based on the attenuated T.gondii strain S48, known as Toxovac®, but the vaccine is only capable to provide a short immunity. Additionally, it is expensive and inappropriate to be applied in human. In recent years, different experimental studies have demonstrated the probability of developing a new vaccine. This paper tries to highlight the history of discovering the first commercial vaccine against toxoplasmosis in sheep, along with recent advances in the field and shining a light to the current status of vaccine trials.


DubeyJ.P. and BeattieC.P.,'' Toxoplasmosis in animals and man''In:

ElsheikhaH.M.''Congenital toxoplasmosis: priorities for further health promotion action''. Public

Health.122, pp. 335-353, (2008). DOI:

Tizard I., ''Veterinary immunology''. 9th Ed. Elsevier. Texas. (2013).

Edwards J. F. and Dubey J. P., ''Toxoplasma gondii abortion storm in sheep on a Texas farm

and isolation of mouse virulent atypical genotype T. gondii from an aborted lamb from a

chronically infected ewe''. Veterinary parasitology, 192, pp. 129-136, (2013). DOI:

Dubey J. P., ''History of the discovery of the life cycle of Toxoplasma gondii'', International

journal of parasitology, 39, 877-882, (2009). DOI:

Hill D.E. and Dubey.J. P, ''Toxoplasma gondii prevalence in farm animals in the united

states''. International journal for parasitology, 43, pp. 107-113, (2013). DOI:

MontoyaJ.G. and Liesenfeld O., ''Toxoplasmosis''. The lancet, 363 (9425), pp.1965-1976, DOI:


Dubey.J. P., ''Toxoplasmosis in sheep-the last 20 years''. Veterinary parasitology, 163, pp.1- DOI:

, (2009).

KumarH., Kawai T., and Akira S., ''Toll-like receptors and innate immunity''. Biochemical

and Biophysical research communication, 388(4), pp. 621-625, (2009). DOI:

Alberti J., and Bafica A., ''Anti-inflammatory pathways as a host evasion mechanism for

pathogens''. Prostaglandins, Leukotrienes and Essential Fatty Acids, 73, pp. 283-288, (2005). DOI:

Ibrahim H. M., Xuan X., and Nishikawa Y., ''TosxoplasmagondiiCyclophilin 18 regulates

the proliferation and migration of murine macrophages and spleen cells”.Clinical and vaccine

immunology, 17(9), pp. 1322-1329, (2010). DOI:

MillerC.M., BoulterN.R., IkinR.J., and Smith N.C., ''The immunobiology of the innate

response to Toxoplasma gondii''. International journal for parasitology, 39, pp. 23-39, (2009). DOI:

Liu Q., Singla L.D., and Zhou H., ''Vaccines against Toxoplasma gondii''. Human vaccines

and immunotherapeutics, 8 (9), pp. 1305-1308, (2012). DOI:

KurJ., Holec-GasiorL.andHiszcynska-Sawicka E., ''Current status of toxoplasmosis vaccine

development''. Experst Review Vaccine, 8(6), pp. 791-808, (2009). DOI:

BillkerO., LouridoS., and SibleyL. D.,'' Calcium-Dependent signalling and Kinases in

Apicomplexian Parasites''. Cell host & Microbe, 5, 612-622, (2009). DOI:

Innes E. A., Panton W. R., and Sanderson A., Thomson K. M. Wastling J. M. Maley S., and

Boxton D., ''Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to

Toxoplasma gondii infection: analysis of phenotype and function''. Parasite immunology, 17, pp.

-160, (1995).

SuzueK., AsaiT., Takeuchi T., and Koyasu S., ''In vivo role of IFN- gamma produced by

antigenpresenting cells in early host defense against intracellular pathogens''. European journal of

immunology, 33, pp. 2666-2675, (2003). DOI:

ZhouH., MinJ., ZhaoQ., Gu et al. ''Protective immune response against Toxoplasma gondii

elicited by a recombinant DNA vaccine with a novel genetic adjuvant''. Vaccine, 30, pp. 1800- DOI:

, (2012).

O’connellE., Wilkins M. F., and PungaW. A., '' Toxoplasmosis in sheep. II. The ability of a

live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii''.

Newzland veterinary journal, 36, pp. 1-4, (1988).

Buxton D., ''Toxoplasmosis: the First Commercial Vaccine''. Parasitology Today, 9(9), pp. DOI:

-337, (1993).

Buxton D., Thomson K., Maley S., Wastling J. M., Innes E. A. Panton W. R., and Nicoll S.

''Primary and Secondary Responses of the Ovine Lymph Node to Toxoplasma gondii: Cell

Output in Efferent Lymph and Parasite Detection''. Journal of comparative pathology, 111, 231-

, (1994).

Buxton D., and Innes E., ''A commercial vaccine for ovine toxoplasmosis''.Parasitology, 110, DOI:

pp. S11-S16, (1995).

Buxton D., Thomson K., Maley S., Wright S., and Bos H. J., ''Vaccination of sheep with a

live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when

pregnant''. The veterinary record, 129, pp. 89-93, (1991). DOI:

Falcon J., and Freyre A., ''Toxoplasma gondii: prototype immunization of lambs against

formation of muscle and brain cyst''. Veterinary parasitology, 166, pp. 15-20, (2009). DOI:

Araujo F., and Slifer T., ''Different Strains of Toxoplasma gondii Induce Different Cytokine

Responses in CBA/Ca Mice''. Infection and Immunity, 71(7), pp. 4171-4174, (2003). DOI:

Freyre A., Falcon J., Mendez J., and Gonzalez M., ''Toxoplasma gondii: protection against

colonization of the brain and muscles in a rat model''. Experimental parasitology, 119, pp. 252-

, (2008).

Babiuk S., TsangC.,vanDrunen L. H. S. ''A single HBsAg DNA vaccination in combination

with electroporation elicits long-term antibody responses in sheep''. Biochemistry, 70, pp. 269- DOI:

, (2007).

HiszczynskaE., Li H.,Xu J. B., Oledzka G., Kur, J., Bickerstaffe R., and Stankiewicz M.,

''Comparision of immune response in sheep immunized with DNA vaccine encoding Toxoplasma

gondii GRA7 antigen in different adjuvant formulations''. Experimental Parasitology, 124, pp.

-372, (2010).

Hadad D., Bilcikova E., Witney A. A., Carlton J., White C. E., and Blair P. L., et al.''Novel

antigen identification method for discovery of protective Malaria antigens by rapid testing of

DNA vaccines encoding Exons from the parasite genome''. Infection and Immunity, 72(3), pp.

-1602, (2004).

Gurunathan S., Sacks D. L., Brown D. R., Reiner S. L., Charest H., Glaichenhaus N., and

Seder R. A., ''Vaccination with DNAencoding the immunodominant LACK parasite antigen

confers protective immunity to mice infected with Leishmania major''. Journal of experimental

medicine,186, pp.1137–47, (1997).

Min J., QuD., Li C., Song X, Zhoa Q., and Li X. A., et al., ''Enhancement of protective

immune responses induced by Toxoplasma gondii dense granule antigen 7(GRA7) against

toxoplasmosis in mice using a prime-boost vaccineation strategy''. Vaccine, 30, pp. 5631-5636,


Jongert E., de Craeye S., Dewit J., and Huygen K., ''GRA7 provides protective immunity in

cocktail DNA vaccines against Toxoplasma gondii''. Parasite immunology, 29, pp. 445-453,


SoldatiD., Dubremets J., and LebrunM., ''Microneme proteins: structural and functional

requirments to promote adhesion and invation by apicomplexian parasite Toxoplasma gondii''.

International Journal for Parasitology, 31, pp. 1293-1302, (2001). DOI:

Tomely F., and SoldatiD., ''Mix and match modules: structure and function of microneme

proteins in apicomplexian parasites''. Trends in Parasitology, 17(2), pp. 81-88, (2001). DOI:

IsmaelA. B., Sekkai D., CollinC.,Bout D., and Mevelec M.,'' The MIC3 Gene of Toxoplasma

gondii is a novel potent vaccine candidate against Toxoplasmosis''. Infection and Immunity,

(11), pp. 6222-6228, (2003).

Beghetto E., Niesen H. V., Del Porto P., Buffolano W., Guglietta S., Felici F., Petersen E.

and Gargano N.,''A combination of antigenic region of Toxoplasma gondiimiconeme proteins

induces protective immunity against oral infection with parasitic cysts''. The Journal of Infectious

Diseases, 191, pp. 637-645, (2005). DOI:

Hiszczynska-Sawicka E., Li H., Bouu X., J., Akhtar M., Jolec-Gasior L., Bickersaffe R., and

Stankiewicz M., ''Induction of immune responses in sheep by vaccination with liposome-

enterapped DNA complexes encoding Toxoplasma gondii MIC3 gene''. Polish journal of

veterinary sciences, 15(1), pp. 3-9, (2012).

Kim S., and Boothroyd J., ''Stage specific expression of surface antigens by Toxoplasma

gondiias a mechanism to facilitate parasite persistence''. Journal of immunology, 174 (12), pp.

-8048, (2005).

Cesbron-DelauwM. F. and CapronA.. ''Excreted/secreted antigens of Toxoplasma gondii-

their origin and role in the host-parasite interaction''.Research in Immunology, 144(1), pp. 41-44,


Tomavo S., '' The major surface proteins of Toxoplasma gondii: Structure and functions''.

Current topics in Microbioology and Immunology, 219, pp. 45-54, (1996).

Debard N., Buzoni-Gatel D., and Bout D., ''Intranasal immunization with SAG1 protein of

Toxoplasma gondii in association with cholera toxin dramatically reduces development of

cerebral cycts after oral infection''. Infection and Immunity, 64(6), pp. 2158-2166, (1996). DOI:

Letscher-Bru V., Villard O.,Risse B., Zauke M., Klein J. P., and Kien T. T., ''Protective

effect of vaccination with a combination of recombinant surface antigen 1 and Interleukin-12

against Toxoplasmosis in mice''. Infection and Immunity, 66(9), pp. 4503-4506, (1998). DOI:

AngusC. W., Klivinton-EvansD., Dubey J. P. and Kovacs J. A., ''Immunization with a DNA

plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective

in rodents''. Journal of Infectious Diseases, 181, pp. 317-324, (2000). DOI:

Li B., Oledzka G.,McFarlane R. G., Spellerberg M. B., Smith S. M., Gelder F.B. Kur J.,

Stankiewicz M., ''Immunological responses of sheep to injections of plasmid encoding

Toxoplasma gondiiSAG1 and ROP1 genes''. Parasite Immunology, 32, pp. 671-683, (2010). DOI:

Rodgers L., Wang X., Wen X., Dunford B., Miller R., and Suzuki Y., ''Strains of

Toxoplasma gondiiused for tachyzoite antigens to stimulate spleen cells of infected mice in vitro

affect cytokine responses of the cells in the culture''. Parasitology Research, 97(4), pp. 332-335,


Tilley M., Fichera M. E. Jerome M. E., Roos D. S., and White M. W., ''Toxoplasma

gondiisporozoites form a transient parasitophorous vacuole that is impermeable and contains only

a subset of dense-granule proteins''.Infection and immunity, 65(11), pp. 4598-4605, (1997). DOI:

Supply P., Sutton P., Coughlan S. N., Bilo K., Saman E., Trees A. J., CesbronDelauw M. F.

and Locht C. ''Immunogenecity of recombinant BCG producing the GRA1 antigen from

Toxoplasma gondii''. Vaccine, 17, 705-714, (1997).

Min J., QuD., Li C., Song X., Zhao Q., Li X. A., Yang Y., Liu Q., He S., and Zhou H.,

''Enhancement of protective immune responses induced by Toxoplasma gondii dense granule

antigen 7(GRA7) against toxoplasmosis in mice using a prime-boost vaccineation strategy''.

Vaccine, 30, pp. 5631-5636, (2012). DOI:

Fischer h. G., Stachelhaus S., Sahm M., Meyer H. E., and Reichmann G., ''GRA7, an

excretory 25kDa Toxoplasma gondii dense granule antigen released by infected host cells''.

Molecular and Biochemical parasitology, 91, pp. 251-262, (1998). DOI:

Hiszczynska-Sawicka E., OledzkaG., Holec-Gasior L., Li H., Xu J. B., Sedcole R., Kur J.,

Bickerstaffe R., Stankiewicz M., ''Evaluation of immune response in sheep induced by DNA

immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma

gondii''. Veterinary parasitology, 177, 281-289, (2011) DOI:

Hyde S. C., Southern K. W., Gileadi U., Fitzjohn E. M. Mofford K. A. Waddell B. E., et al.,

''Repeat administration of DNA/liposome to the nasal epithelium of patients with cystic fibrosis''.

Gene therapy, 7, 1156-1165, (2000). DOI:

Scorza T., Souza S., LaloupM., Dewit J., Breakeleer J. D. Verschueren H., et al., ''A GRA1

DNA vaccine primes cytolytic CD8+ T cells to control acute Toxoplasma gondii infection''.

Infection and Immunity, 71(1), 309-316, (2003). DOI:

Vercammen M., Scorza T., HugenK., Braekeleer J. D. Diet R., Jacobs D., et al., ''DNA

Vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces

partially protective immunity against lethal challange in mice''. Infection and Immunity, 68(1),

-45, (2000).

CarruthersV. B. and Sibley L. D., ''Sequential protein secretion from three distinct organelles

of Toxoplasma gondii accompanies invasion of human fibroblast''. European journal of

parasitology, 73(2), 114-123, (1997). DOI:

Costa-Silva T. A., MeiraC. S., FerreiraI. M. Hiramoto M., and Pereira-Chiccola

VL.''Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel

succeptible mouse model (A/Sn) for Toxoplasma gondii''.Experimental parasitology, 120, pp.

234, (2008).

SafferL. D., Mercerau-PuijalonO., Dubremetz J. F. and Schwartzman J. D., ''Localization of

a Toxoplasma gondiirhoptry protein by immunoelectron microscopy during and after host cell

penetration''. Journal of protozoology, 39(4), 526-530, (1992). DOI:

Dlugonska H., ''ToxoplsmaRhoptries: Unique secretory organelles source of promising

vaccine proteins for immunoprevention of Toxoplasmosis''. Journal of Biomedicine and

Biotechnology, pp. 1-7, (2008).

Leyva R., HerionP., and Saavedra R., ''Genetic immunization with plasmid DNA coding for

the ROP2 protein of Toxoplasma gondii''. Parasitology research, 87(1), pp. 70-79, (2001). DOI:

Mishima M., Xuan X., Yokoyama N., Igarashi I., Fujisaki K., Nagasawa H., and Mikami

Takeshi., ''Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen

inducible protective immunity in cats''. Parasitology Research, 88(2), pp. 144-149, (2002). DOI:

Zheng B., Lu S., Tong Q., Kong Q., and Luo D., ''The virulence-related rhoptry 5 (ROP5) of

Toxoplasma gondiiis a novel vaccine candidate against toxoplasmosis on mice''. Vaccine, 31, pp.

-4584, (2013).

Yuan Z. G. Zhang X. X., He X. H., Petersen E., Zhou D. H. and Yong H., et al., ''Protective

immunity induced by Toxoplasma gondiiRhoptry protein 16 against Toxoplasmosis in Mice''.

Clinical and Vaccine Immunology, 18(1), pp. 119-124, (2011). DOI:

Yuan Z. G. Zhang X. X. Lin R. Q. Petersen E., He S., and Yu M., et al.,''Protective effect

against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma

gondii ROP18''. Vaccine, 29, pp. 6614-6619, (2011). DOI:



How to Cite

Vaccines against Ovine Toxoplasmosis: History, Advances and Current status. (2014). Journal of Zankoy Sulaimani - Part A, 16(3), 27-39.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>